Clinical Trials Browser

Stomach Neoplasms

Pancreatic Metastatic Cancer

Clinical Stage 0 Gastric Cancer AJCC v8

Borderline Resectable Pancreatic Adenocarcinoma

Colorectal Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Rectal Neoplasms

Biliary Tract Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Pancreatic Neoplasms

Esophageal Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Locally Advanced Rectal Cancer

Cholangiocarcinoma

Locally Advanced Colorectal Cancer

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

Esophageal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Locally Advanced Rectal Cancer

Colonic Neoplasms

Gastric Adenocarcinoma

Pancreatic Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Stomach Neoplasms

Locally Advanced Rectal Cancer With Liver Metastases

Liver Metastases From Colorectal Cancer (mCRC)

Rectal Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis, Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Cancer Metastatic

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Small Bowel Adenocarcinoma

Locally Advanced Pancreatic Cancer

Advanced Biliary Tract Carcinoma

Colorectal Neoplasms

Clinical Trials

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

PAMELA70

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

AndroMETa-CRC

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

TOGAR

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

LyRICX

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma

ILUSTRO

Toco-CoR

TORCH-iTNT

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

EDGE-Gastric

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

PROTECT

SCOTI

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

TRIUNITE-08

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

PANCREAS

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

DG-03

PASS-01

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

TRIPP-FFX

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer